×
About 23,230 results

ALLMedicine™ Alzheimer Disease Center

Research & Reviews  11,029 results

Editorial: Understanding factors that, beyond plaques and tangles, contribute to the he...
https://doi.org/10.1097/WCO.0000000000000915
Current Opinion in Neurology; Gomez-Isla T

Mar 5th, 2021 - Editorial: Understanding factors that, beyond plaques and tangles, contribute to the heterogeneity of Alzheimer disease and implications for the development of biomarkers and design of interventions.|2021|Gomez-Isla T,|

Alzheimer Disease Clinical Trials Targeting Amyloid: Lessons Learned From Success in Mi...
https://doi.org/10.1097/NRL.0000000000000320
The Neurologist; Reiss AB, Montufar N et. al.

Mar 1st, 2021 - The goal of slowing or halting the development of Alzheimer disease (AD) has resulted in the huge allocation of resources by academic institutions and pharmaceutical companies to the development of new treatments. The etiology of AD is elusive, bu...

Development and Validation of a Community Assessment Survey for Diverse Rural Family Ca...
https://doi.org/10.1097/FCH.0000000000000297
Family & Community Health; McCarthy MJ, Hustead ML et. al.

Mar 1st, 2021 - Many individuals with Alzheimer disease and related dementias receive care from family members and friends. Rurality adds increased complexity to care, especially for diverse caregivers. This study details the development and content validation pr...

Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets Neurode...
https://doi.org/10.1093/jnen/nlab010
Journal of Neuropathology and Experimental Neurology; Sieben A, Van Langenhove T et. al.

Feb 27th, 2021 - Hippocampal sclerosis (HS) is a common neuropathological finding and has been associated with advanced age, TDP-43 proteinopathy, and cerebrovascular pathology. We analyzed neuropathological data of an autopsy cohort of early-onset frontotemporal ...

Vascular Hypothesis of Alzheimer Disease: Topical Review of Mouse Models.
https://doi.org/10.1161/ATVBAHA.120.311911
Arteriosclerosis, Thrombosis, and Vascular Biology; Scheffer S, Hermkens DMA et. al.

Feb 25th, 2021 - Alzheimer disease (AD) is marked by profound neurodegeneration, neuroinflammation, and cognitive decline. Pathologically, AD is characterized by the accumulation of extracellular amyloid and intraneuronal tangles, consisting of hyperphosphorylated...

see more →

Guidelines  59 results

Sex Differences in Cognitive Decline Among US Adults
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2776902
JAMA Network Open; Levine DA, Gross AL et. al.

Feb 24th, 2021 - Sex differences in dementia risk are unclear. It is known that women have a greater prevalence of Alzheimer disease (AD) than men, at least partly because women live longer.1-3 Some, but not all, studies suggest that women have higher incidence of...

ACR Appropriateness Criteria® Dementia.
https://doi.org/10.1016/j.jacr.2020.01.040
Journal of the American College of Radiology : JACR; , Moonis G et. al.

May 6th, 2020 - Degenerative disease of the central nervous system is a growing public health concern. The primary role of neuroimaging in the workup of patients with probable or possible Alzheimer disease has typically been to exclude other significant intracran...

Falls Risk and Alzheimer Disease: A Patient Guide.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252520
Archives of Physical Medicine and Rehabilitation; Kahya M, Sood P et. al.

Mar 2nd, 2020 - Falls Risk and Alzheimer Disease: A Patient Guide.|2020|Kahya M,Sood P,Devos H,Krishnan S,Hirsch MA,|

In Alzheimer Research, Glucose Metabolism Moves to Center Stage
https://jamanetwork.com/journals/jama/fullarticle/2758712
JAMA Kuehn BM

Jan 7th, 2020 - Areas or patterns of reduced glucose metabolism are often seen in brain scans of patients with Alzheimer disease and other dementias. Now, a growing body of evidence suggests that glucose hypometabolism may be more than just a biomarker on brain s...

Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine: a population-based cohort study
http://www.cmaj.ca/content/191/37/E1018
CMAJ

Sep 15th, 2019 - BACKGROUND: Donepezil, rivastigmine and galantamine are popular cholinesterase inhibitors used to manage the symptoms of Alzheimer disease and other dementias; regulatory agencies in several countries warn about a possible risk of rhabdomyolysis w...

see more →

Drugs  5 results see all →

Clinicaltrials.gov  11,529 results

Editorial: Understanding factors that, beyond plaques and tangles, contribute to the he...
https://doi.org/10.1097/WCO.0000000000000915
Current Opinion in Neurology; Gomez-Isla T

Mar 5th, 2021 - Editorial: Understanding factors that, beyond plaques and tangles, contribute to the heterogeneity of Alzheimer disease and implications for the development of biomarkers and design of interventions.|2021|Gomez-Isla T,|

Alzheimer Disease Clinical Trials Targeting Amyloid: Lessons Learned From Success in Mi...
https://doi.org/10.1097/NRL.0000000000000320
The Neurologist; Reiss AB, Montufar N et. al.

Mar 1st, 2021 - The goal of slowing or halting the development of Alzheimer disease (AD) has resulted in the huge allocation of resources by academic institutions and pharmaceutical companies to the development of new treatments. The etiology of AD is elusive, bu...

Development and Validation of a Community Assessment Survey for Diverse Rural Family Ca...
https://doi.org/10.1097/FCH.0000000000000297
Family & Community Health; McCarthy MJ, Hustead ML et. al.

Mar 1st, 2021 - Many individuals with Alzheimer disease and related dementias receive care from family members and friends. Rurality adds increased complexity to care, especially for diverse caregivers. This study details the development and content validation pr...

Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets Neurode...
https://doi.org/10.1093/jnen/nlab010
Journal of Neuropathology and Experimental Neurology; Sieben A, Van Langenhove T et. al.

Feb 27th, 2021 - Hippocampal sclerosis (HS) is a common neuropathological finding and has been associated with advanced age, TDP-43 proteinopathy, and cerebrovascular pathology. We analyzed neuropathological data of an autopsy cohort of early-onset frontotemporal ...

Vascular Hypothesis of Alzheimer Disease: Topical Review of Mouse Models.
https://doi.org/10.1161/ATVBAHA.120.311911
Arteriosclerosis, Thrombosis, and Vascular Biology; Scheffer S, Hermkens DMA et. al.

Feb 25th, 2021 - Alzheimer disease (AD) is marked by profound neurodegeneration, neuroinflammation, and cognitive decline. Pathologically, AD is characterized by the accumulation of extracellular amyloid and intraneuronal tangles, consisting of hyperphosphorylated...

see more →

News  607 results

Sex Differences in Cognitive Decline Among US Adults
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2776902
JAMA Network Open; Levine DA, Gross AL et. al.

Feb 24th, 2021 - Sex differences in dementia risk are unclear. It is known that women have a greater prevalence of Alzheimer disease (AD) than men, at least partly because women live longer.1-3 Some, but not all, studies suggest that women have higher incidence of...

Fast Five Quiz: Alzheimer Disease Management
https://reference.staging.medscape.com/viewarticle/912045_2

Aug 18th, 2020 - Answer 1/5 Which of the following is the current standard pharmacologic treatment for Alzheimer disease in the United States and Europe? Your peers chose: Carbidopa/levodopa/entacapone 0% Cholinesterase inhibitors (ChEIs) and partial N-methyl-D-as...

Fast Five Quiz: Alzheimer Disease Management
https://reference.staging.medscape.com/viewarticle/912045

Aug 18th, 2020 - Alzheimer disease is a chronic, neurodegenerative disorder of the aging population that results in progressive cognitive and behavioral dysfunction. Afflicting more than 6 million Americans and more than 8 million Europeans, Alzheimer disease is t...

Fast Five Quiz: Alzheimer Disease Management
https://reference.staging.medscape.com/viewarticle/912045_5

Aug 18th, 2020 - In addition to the medications approved for Alzheimer disease, regular physical and cognitive exercise routines are strategies to prevent and slow disease progression. Increased cardiorespiratory fitness levels are associated with higher hippocamp...

Fast Five Quiz: Alzheimer Disease Management
https://reference.medscape.com/viewarticle/912045_3

Aug 18th, 2020 - Answer 2/5 Which of the following has been shown to achieve the highest levels of cognitive and functional abilities in patients with Alzheimer disease? Your peers chose: Early diagnosis and treatment 0% Antidepressants 0% Loop diuretics and CCBs ...

see more →

Patient Education  1 results see all →